| Product ID |
CAS Number |
Product Name |
Quantity |
| AS-1379 |
1192-62-7 |
2-Acetylfuran |
|
| AS-1547 |
3622-35-3 |
BENZOTHIAZOLE-6-CARBOXYLIC ACID |
|
| AS-2262 |
450-88-4 |
2-Bromo-5-fluoroanisole |
|
| AS-2412 |
556-99-7 |
5-Bromo-m-xylene |
|
| AS-3126 |
108-00-9 |
2-Dimethylaminoethylamine |
|
| AS-3175 |
183321-74-6 |
Erlotinib |
|
| AS-3519 |
58656-04-5 |
TRICYCLOHEXYLPHOSPHONIUM TETRAFLUOROBORATE |
|
| AS-3859 |
625-92-3 |
3,5-Dibromopyridine |
|
| AS-4353 |
313279-12-8 |
2-Amino-3-nitrobenzamide |
|
| AS-4767 |
26050-64-4 |
4-BROMO-3,5-DIMETHOXYBENZOIC ACID METHYL ESTER |
|
| AS-5016 |
607-34-1 |
5-Nitroquinoline |
|
| AS-5313 |
5001-18-3 |
1,3-Dihydroxyadamantane |
|
| AS-5553 |
550-89-0 |
phenazine-1-carboxamide |
|
| AS-5600 |
2314-97-8 |
Trifluoromethyl iodide |
|
| AS-5737 |
2206-43-1 |
4-Methoxyisophthalic acid |
|
| AS-5880 |
7148-50-7 |
5-methyl-5-propyl-1,3-dioxan-2-one |
|
| AS-6293 |
33259-72-2 |
5,6-DIAMINO-2-PICOLINE, |
|
| AS-6297 |
87327-69-3 |
2'-CHLORO-6'-FLUOROACETOPHENONE |
|
| AS-6875 |
1705-85-7 |
6-METHYLCHRYSENE |
|
| AS-7213 |
635-27-8 |
5-CHLOROQUINOLINE |
|
| AS-7279 |
1119-40-0 |
Dimethyl Glutarate |
|
| AS-7665 |
60456-23-7 |
(S)-Oxiranemethanol |
|
| AS-7917 |
585-32-0 |
CUMYLAMINE |
|
| AS-7967 |
9/2/3481 |
N-Chlorophthalimide |
|
| AS-8648 |
52794-99-7 |
3,4-Dichlorophenylalanine |
|
| AS-8859 |
97-09-6 |
4-Chloro-3-nitrobenzenesulfonamide |
|
| AS-8902 |
13679-70-4 |
5-Methylthiophene-2-carboxaldehyde |
|
| AS-8909 |
69383-59-1 |
1-BROMO-2,4-DIMETHYL-5-NITROBENZENE |
|
| AS-8910 |
286946-77-8 |
5-BROMO-2-CHLORO-PYRIDIN-3-OL |
|
| JR6-L2338 |
885971-52-8 |
Ethanone, 1-[(4R)-4-phenyl-2-thioxo-3-thiazolidinyl]- |
|
| JR6-L3155 |
873439-62-4 |
[1,1'-Binaphthalene]-3-carboxaldehyde, 2-hydroxy-2'-methoxy-, (1R)- |
|
| JR6-L3566 |
89922-82-7 |
Propanal, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]- |
|
| JR6-L4919 |
16728-00-0 |
Cyclopropanecarbonitrile, 1-(4-methoxyphenyl)- |
|
| JR6-L7929 |
1344639-99-1 |
2H-Indol-2-one, 3-amino-6-bromo-1,3-dihydro-3-methyl-, (3R)- |
|
|
|
|
|
|
|
|
|
|
|
|
|